TLX · Telix Pharmaceuticals Limited
15.68
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$5.32B
PE
3026.10
EV/EBITDA
69.7
DIV Yield
0%
Franking
0%
MQV Rating
2Strong
As at 25/06/2026 04:13:50 PM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- Consensus Cheap
- EMA 125 Breakup
- Extreme Overbought (Realtime)
- GROWTH AUS
- HALO 100
- HALO 200
- HALO Growth
- HALO Momentum
- HALO Ords
- HALO Price Momentum
- Near Resistance (Realtime)
- Short Sold <-1 over the month
- Short Term Trend - Long
Key Fundamentals
EPS 3 yr Growth
-90.90%
EBITDA Margin
4.90%
Operating Cashflow
-$17m
Free Cash Flow Return
-2.20%
ROIC
-0.90%
Interest Coverage
1.10
Quick Ratio
1.30
Performance
52 weeks range
Low 8.26 - 25.87
Trade Value (12mth)
US$6,221,853.00
1 week
11.17%
1 month
18.9%
YTD
38.47%
1 year
-35.59%
All time high
31.97
Additional Data
Shares Outstanding (Fully Diluted)
339m
HALO Sector
Healthcare
Next Company Report Date
19-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
12.58
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Neutral
Halo Model
Mqv
Strong
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Strong
Growth
Earnings
Very Strong
Dividends
Very Weak
Quality
Capital Efficiency
Neutral
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
25 June 26ASXD | |
23 June 26ASXD | |
17 June 26ASXD | |
09 June 26ASXD | |
01 June 26ASXD |
